| Report ID | Date of report | Patient age | Patient gender |
| 21021 | Dec, 30, 2005 | 58 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Ditropan Xl | oxybutynin chloride |
Evista | raloxifene hydrochloride |
Hyzaar | hydrochlorothiazide; losartan potassium |
| Name |
Blood Albumin Decreased |
Blood Creatinine Increased |
Blood Glucose Increased |
Blood Urea Increased |
Blood Urea Nitrogen/creatinine Ratio Increased |
Carbon Dioxide Decreased |
Disease Progression |
Hepatic Failure |
Hyperbilirubinaemia |
Results from eHealthMe : 4 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Blood Albumin Decreased | 3 (75.00%) |
Blood Creatinine Increased | 3 (75.00%) |
Blood Glucose Increased | 3 (75.00%) |
Blood Urea Increased | 3 (75.00%) |
Blood Urea Nitrogen/creatinine Ratio Increased | 3 (75.00%) |
Carbon Dioxide Decreased | 3 (75.00%) |
Disease Progression | 3 (75.00%) |
Hepatic Failure | 3 (75.00%) |
Hyperbilirubinaemia | 3 (75.00%) |
Top 3 (total: 1. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Visudyne | 1 (7.69%) |
Death reported: 0
| Name | Count (% of total reports) |
Disease Progression | 3 (75.00%) |
Hepatic Failure | 3 (75.00%) |
Blood Albumin Decreased | 3 (75.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
